XML 45 R23.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2022
FINANCIAL INSTRUMENTS  
FINANCIAL INSTRUMENTS

NOTE 17 — FINANCIAL INSTRUMENTS

a) General considerations - Gerdau S.A. and its subsidiaries enter into transactions with financial instruments whose risks are managed through market strategies discussed and shared with senior management and in accordance with internal guidelines and control systems for exposure limits to them. All financial instruments are recorded in the accounting books and presented as short-term investments, trade accounts receivable, trade accounts payable – domestic market, trade accounts payable – debtor risk, trade accounts payable - imports, loans and financing, debentures, related parties, fair value of derivatives, obligations with FIDC, other current assets, other non-current assets, other current liabilities and other non-current liabilities.

The Company has derivatives and non-derivative instruments, such as the hedge for some operations under hedge accounting. These operations are intended to protect the Company against exchange rate fluctuations on foreign currency loans, interest rate and commodity prices fluctuations. These transactions are carried out considering direct active or passive exposures, without leverage.

b) Fair Value  — the Fair Value of the financial instruments is as follows:

2022

2021

    

Book

    

Fair

    

Book

    

Fair

value

value

value

value

Assets

 

  

 

  

 

  

 

  

Short-term investments

 

2,959,135

 

2,959,135

 

2,626,212

 

2,626,212

Trade accounts receivable - net

4,999,004

4,999,004

5,414,075

5,414,075

Related parties

 

 

 

2,678

 

2,678

Fair value of derivatives

 

3,272

 

3,272

 

3,246

 

3,246

Other current assets

 

789,901

 

789,901

 

679,193

 

679,193

Other non-current assets

 

700,377

 

700,377

 

571,637

 

571,637

Liabilities

 

 

 

 

Trade accounts payable - domestic market

4,241,819

4,241,819

5,277,867

5,277,867

Trade accounts payable - debtor risk

653,085

653,085

807,915

807,915

Trade accounts payable - imports

1,724,019

1,724,019

1,931,358

1,931,358

Loans and Financing

 

11,179,617

 

11,267,779

 

11,109,786

 

12,630,940

Debentures

 

1,427,773

 

1,421,187

 

2,929,907

 

2,911,424

Related parties

24,890

24,890

24,648

24,648

Fair value of derivatives

 

19,056

 

19,056

 

 

Obligations with FIDC (current liabilities)

 

 

 

45,497

 

45,497

Other current liabilities

 

1,216,206

 

1,216,206

 

1,090,396

 

1,090,396

Other non-current liabilities

 

533,681

 

533,681

 

421,873

 

421,873

The fair values of Loans and Financing and Debentures are based on market premises, which may take into consideration discounted cash flows using equivalent market rates and credit rating. All other financial instruments, which are recognized in the Consolidated Financial Statements at their carrying amount, are substantially similar to those that would be obtained if they were traded in the market. However, because there is no active market for these instruments, differences could exist if they were settled in advance. The fair value hierarchy of the financial instruments above are presented in Note 17.g.

c) Risk factors that could affect the Company’s and its subsidiaries’ businesses:

Price risk of commodities: this risk is related to the possibility of changes in prices of the products sold by the Company or in prices of raw materials and other inputs used in the productive process. Since the Company operates in a commodity market, net sales and cost of sales may be affected by changes in the international prices of their products or materials. In order to minimize this risk, the Company constantly monitors the price variations in the domestic and international markets. Furthermore, the Company may contract derivatives in order to reduce this risk.

Interest rate risk: this risk arises from the effects of fluctuations in interest rates applied to the Company’s financial liabilities or assets and future cash flows and income. The Company evaluates its exposure to these risks: (i) comparing financial assets and liabilities denominated at fixed and floating interest rates and (ii) monitoring the variations of interest rates like SOFR and CDI. Accordingly, the Company may enter into interest rate swaps in order to reduce this risk.

Exchange rate risk: this risk is related to the possibility of fluctuations in exchange rates affecting the amounts of financial assets or liabilities or of future cash flows and income. The Company assesses its exposure to the exchange rate by measuring the difference between the amount of its assets and liabilities in foreign currency. The Company understands that the accounts receivables originated from exports, its cash and cash equivalents denominated in foreign currencies and its investments abroad are more than equivalent to its liabilities denominated in foreign currency. Since the management of these exposures occurs at each operation level, if there is a mismatch between assets and liabilities denominated in foreign currency, the Company may contract derivative financial instruments in order to mitigate the effect of exchange rate fluctuations.

Credit risk: this risk arises from the possibility of the Company not receiving amounts arising from sales to customers or investments made with financial institutions. In order to minimize this risk, the Company adopt the procedure of analyzing in details of the financial position of their customers, establishing a credit limit and constantly monitoring their balances. Regarding financial

investments, the Company only carries out transactions with first-rate institutions and with low credit risk, as assessed by rating agencies and risk mitigation parameters defined in the Company’s internal guidelines.

Capital management risk: this risk comes from the Company’s choice in adopting a financing structure for its operations. The Company manages its capital structure, which consists of a ratio between the financial debts and its own capital (Equity) based on internal policies and benchmarks. The Key Performance Indicators (KPI) related to the “Capital Structure Management” objective are: WACC (Weighted Average Cost of Capital), Net Debt/EBITDA (Earnings before interest, income tax, depreciation and amortization), Coverage Ratio of Net Financial Expenses (EBITDA/Net Financial Expenses) and Debt/Total Capitalization Ratio. Net Debt is formed by the principal of the debt reduced by cash, cash equivalents and short-term investments (notes 4, 15 and 16). Total Capitalization is formed by the Total Debt (composed of the principal of the debt) and the Equity (Note 24). The Company may change its capital structure, according to economic and financial conditions, in order to optimize its financial leverage and debt management. At the same time, the Company seeks to improve its ROCE (Return on Capital Employed) through the implementation of working capital management and an efficient program of investments in property, plant and equipment. In the long term, the Company seeks to remain within the parameters below, admitting occasional variations in the short term:

Net debt/EBITDA

     

Less or equal to 1.5 times

Gross debt limit

R$ 12 billion

Average maturity

more than 6 years

These key indicators are used to monitor objectives described above and may not necessarily be used as indicators for other purposes, such as impairment tests.

Liquidity risk: The Company’s management policy of indebtedness and cash on hand is based on using the committed lines and the currently available credit lines with or without a guarantee in export receivables for maintaining adequate levels of short, medium, and long-term liquidity. The maturity of long-term loans and financing, and debentures are presented in Notes 15 and 16, respectively.

2022

Contractual obligations

    

Total

    

Less than 1 year

    

1-3 years

    

4-5 years

    

More than 5 years

Trade accounts payable - domestic market

 

4,241,819

4,241,819

Trade accounts payable - debtor risk

 

653,085

653,085

Trade accounts payable - import

 

1,724,019

1,724,019

Loans and financing

17,262,024

2,492,262

1,987,699

1,369,784

11,412,279

Debentures

 

1,863,925

628,886

270,236

964,803

Related parties

 

24,890

 

24,890

 

 

 

Obligations with FIDC

 

19,056

19,056

Other current liabilities

 

1,216,206

1,216,206

Other non-current liabilities

533,681

45,431

488,250

27,538,705

11,000,223

2,303,366

2,334,586

11,900,529

2021

Contractual obligations

    

Total

    

Less than 1 year

    

1-3 years

    

4-5 years

    

More than 5 years

Trade accounts payable - domestic market

 

5,277,867

5,277,867

Trade accounts payable - debtor risk

 

807,915

807,915

Trade accounts payable - import

 

1,931,358

1,931,358

Loans and financing

17,885,672

851,225

2,227,608

2,308,361

12,498,477

Debentures

 

3,492,689

1,802,373

780,537

111,218

798,561

Related parties

 

24,648

 

 

 

 

24,648

Obligations with FIDC

 

45,497

45,497

Other current liabilities

 

1,090,396

1,090,396

Other non-current liabilities

421,873

35,406

386,467

30,977,915

11,806,631

3,043,551

2,419,579

13,708,153

Sensitivity analysis:

The Company performed a sensitivity analysis, which can be summarized as follows:

Impacts on Statements of Income

Assumptions

    

Percentage of change

    

2022

    

2021

Foreign currency sensitivity analysis

 

5%

 

113,778

 

19,036

Interest rate sensitivity analysis

 

10 bps

 

32,377

 

55,964

Sensitivity analysis of changes in prices of products sold

 

1%

 

824,122

 

783,451

Sensitivity analysis of changes in raw material and commodity prices

 

1%

 

486,066

 

437,210

Currency forward contracts

5%

9,507

Commodity contracts

5%

2,899

4,892

Foreign currency sensitivity analysis: As of December 31, 2022, the Company is mainly exposed to variations between the Real and the Dollar. The sensitivity analysis carried out by the Company considers the effects of a 5% increase or decrease between the Real and the Dollar in its non-hedged debts, trade accounts receivable - exports from Brazil and trade accounts payable - imports (also including the variation between the Argentinian Peso and the Dollar). In this analysis, if the Real/Argentinian Peso appreciates against the Dollar, this would represent a gain of R$ 113,778 (R$ 19,036 as of December 31, 2021). If the Real/Argentinian Peso depreciates against the Dollar, this would represent an expense of the same amount.

The net values of other assets and other liabilities in foreign currencies do not present significant risks of impacts due to fluctuations in the exchange rate.

Interest rate sensitivity analysis: The interest rate sensitivity analysis made by the Company considers the effects of an increase or reduction of 10 basis point (bps) on the average interest rate applicable to the floating part of its debt. The calculated impact, considering this variation in the interest rate totals R$ 32,377 as of December 31, 2022 (R$ 55,964 as of December 31, 2021) and would impact the Financial expenses account in the Consolidated Statements of Income. The specific interest rates to which the Company is exposed are related to the loans, financing, and debentures presented in Notes 15 and 16, and are mainly comprised by SOFR and CDI — Interbank Deposit Certificate.

Sensitivity analysis of changes in sales price of products and price of raw materials and other inputs used in production: The Company is exposed to changes in the price of its products. This exposure is associated with the fluctuation of the sale price of the Company’s products and the price of raw materials and other inputs used in the production process, mainly for operating in a commodity market. The sensitivity analysis made by the Company considers the effects of an increase or of a reduction of 1% on both prices. The impact measured considering this variation in the price of products sold, considering the revenues and costs for the year ended on December 31, 2022, totals R$ 824,122 (R$ 783,451 as of December 31, 2021) and the variation in the price of raw materials and other inputs totals R$ 486,066 as of December 31, 2022 (R$ 437,210 as of December 31, 2021). The impact in the price of products sold and raw materials would be recorded in the accounts Net Sales and Cost of Sales, respectively, in the Consolidated Statements of Income. The Company does not expect to be more vulnerable to a change in one or more specific product or raw material.

Sensitivity analysis of currency forward contracts: the Company has exposure to dollar forward contracts for some of its assets and liabilities. The sensitivity analysis carried out by the Company considers the effects of a 5% increase or decrease in the Dollar against the Brazilian Real/Argentinian Peso, and its effects on the mark to market of these derivatives. A 5% increase in the Dollar against the Real/Argentinian Peso represents an income of R$ 9,507 (R$ 0 as of December 31, 2021) and a 5% decrease in the Dollar against the Real/Argentinian Peso represents an expense of the same amount. Forward contracts in Dollar/Real/Argentinian Peso were intended to cover asset and liability positions in Dollars and the effects of the mark to market of these contracts were recorded in the Consolidated Statement of Income. Dollar forward contracts to which the Company is exposed are presented in note 17.e.

Sensitivity analysis of commodity forward contracts: the Company has exposure to Commodity forward contracts (coal, natural gas and nickel) for some of its liabilities. The sensitivity analysis carried out by the Company considers the effects of a 5% increase or decrease in the price of the commodity, and its effects on the mark to market of these derivatives. A 5% increase in the price of the commodity represents an income of R$ 2,899 (R$ 4,892 as of December 31, 2021), and a 5% decrease in the price of the commodity represents an expense of the same amount. Coal forward contracts were intended to cover liability positions and the mark to market effects of these contracts were recorded in the Consolidated Statement of Income. Commodity forward contracts to which the Company is exposed are presented in Note 17.e.

d) Financial Instruments per Category

Summary of the financial instruments per category:

Financial asset at fair 

 

2022

Financial asset at 

value through proft or 

 

Assets

    

amortized cost

    

loss

    

Total

Short-term investments

 

 

2,959,135

2,959,135

Trade accounts receivable - net

4,999,004

4,999,004

Fair value of derivatives

 

3,272

3,272

Other current assets

 

789,901

 

789,901

Other non-current assets

 

559,389

 

140,988

700,377

Total

 

6,348,294

 

3,103,395

9,451,689

Financial income (expenses)

 

318,105

 

475,910

794,015

Financial liability at fair

 value through profit or 

Financial liability at 

Liabilities

    

loss

    

amortized cost

    

Total

Trade accounts payable - domestic market

 

4,241,819

4,241,819

Trade accounts payable - debtor risk

 

653,085

653,085

Trade accounts payable - import

 

1,724,019

1,724,019

Loans and financing

11,179,617

11,179,617

Debentures

 

1,427,773

1,427,773

Related parties

24,890

24,890

Other current liabilities

 

1,216,206

1,216,206

Other non-current liabilities

533,681

533,681

Fair value of derivatives

19,056

19,056

Total

19,056

21,001,090

21,020,146

Financial income (expenses)

 

(44,386)

(2,642,055)

(2,686,441)

Financial asset at fair 

2021

Financial asset at 

value through proft or 

Assets

amortized cost

    

loss

    

Total

Short-term investments

 

 

2,626,212

2,626,212

Trade accounts receivable - net

5,414,075

5,414,075

Related parties

 

2,678

 

2,678

Fair value of derivatives

 

 

3,246

3,246

Other current assets

 

679,193

 

679,193

Other non-current assets

 

479,971

 

91,666

571,637

Total

 

6,575,917

 

2,721,124

9,297,041

Financial income (expenses)

1,226,743

210,988

1,437,731

Financial liability at fair

 value through profit or 

Financial liability at 

Liabilities

    

loss

    

amortized cost

    

Total

Trade accounts payable - domestic market

 

5,277,867

5,277,867

Trade accounts payable - drawn risk

 

807,915

807,915

Trade accounts payable - import

1,931,358

1,931,358

Loans and financing

 

11,109,786

11,109,786

Debentures

 

2,929,907

2,929,907

Related parties

 

24,648

24,648

Obligations with FIDC (current liabilities)

 

45,497

45,497

Other current liabilities

1,090,396

1,090,396

Other non-current liabilities

421,873

421,873

Total

23,639,247

23,639,247

Financial income (expenses)

 

(10,421)

(2,177,764)

(2,188,185)

e) Operations with derivative financial instruments

Risk management objectives and strategies: In order to execute its strategy of sustainable growth, the Company implements risk management strategies in order to mitigate market risks.

The objective of derivative transactions is always related to mitigating market risks as stated in our policies and guidelines. The monitoring of the effects of these transactions is performed monthly by the Financial Risk Management Committee, which validates the mark to market of these transactions. All derivative financial instruments are recognized at fair value in the Consolidated Financial Statements of the Company.

Policy for use of derivatives: The Company is exposed to various market risks, including changes in exchange rates, commodities prices and interest rates. The Company uses derivatives and other financial instruments to reduce the impact of such risks on the fair value of its assets and liabilities or in future cash flows and income. The Company has established policies to evaluate the market risks and to approve the use of derivative transactions related to these risks. The Company enters into derivative financial instruments solely to manage the market risks mentioned above and never for speculative purposes. Derivative financial instruments are used only when they have a related position (asset or liability exposure) resulting from business operations, investments and financing.

Policy for determining fair value: the fair value of derivative financial instruments is determined using models and other valuation techniques, including future prices and market curves.

Derivative transactions may include: interest rate and/or currency swaps, currency futures contracts and currency options contracts.

Currency forward contracts: The Company contracted forward contract operations, through which it receives a fixed dollar amount and pays a fixed Argentinian peso amount, both in local currency. Counterparties are always top-tier financial institutions with low credit risk.

The derivatives instruments can be summarized and categorized as follows:

Notional value

Amount receivable

Amount payable

Contracts

    

Position

    

2022

    

2021

    

2022

    

2021

    

2022

    

2021

Currency forward contracts

Maturity in 2022

buyed in US$

US$ 5.3 milion

3,246

Maturity in 2023

buyed in US$

US$ 30.9 million

17,950

Commodity contracts

Maturity in 2023/2024

buyed in US$

US$ 2.4 million

3,272

1,106

Total fair value of financial instruments

3,272

3,246

19,056

Fair value of derivatives

    

2022

    

2021

Current assets

 

3,272

 

3,246

3,272

3,246

Fair value of derivatives

Current liabilities

19,056

 

19,056

 

    

2022

    

2021

Net Income

 

  

 

  

Gains on financial instruments

 

83,465

 

28,349

Losses on financial instruments

 

(44,386)

 

(10,421)

 

39,079

 

17,928

Other comprehensive income

 

  

 

  

Gains on financial instruments

 

 

1,907

Losses on financial instruments

(607)

 

(607)

 

1,907

f) Net investment hedge

The Company designated as hedge of part of its net investments in subsidiaries abroad the operations of Ten/Thirty Years Bonds. As a consequence, the effect of exchange rate changes on these debts on the amount of US$ 1.1 billion (designated as a hedge) has been recognized in the Statement of Comprehensive Income.

The Company demonstrated effectiveness of the hedge as of its designation dates and demonstrated the high effectiveness of the hedge from the contracting of each debt for the acquisition of these companies abroad, whose effects were measured and recognized directly in the Statement of Comprehensive Income as an unrealized gain, net of taxes, in the amount R$ 488.146 for the year ended on December 31, 2022 (loss of R$ 695,102 for the year ended on December 31, 2021).

The objective of the hedge is to protect, during the existence of the debt, the amount of part of the Company’s investment in the subsidiaries abroad mentioned above against positive and negative changes in the exchange rate. This objective is consistent with the Company’s risk management strategy. Prospective and retrospective tests demonstrated the effectiveness of these instruments.

g) Measurement of fair value:

IFRS defines fair value as the amount for which an asset could be exchanged, or a liability settled, between knowledgeable, willing parties in an arm’s length transaction. The standard also establishes a three-level hierarchy for the fair value, which prioritizes information when measuring the fair value by the company, to maximize the use of observable information and minimize the use of non-observable information. This IFRS describes the three levels of information to be used to measure fair value:

Level 1 - quoted prices (unadjusted) in active markets for identical assets and liabilities.

Level 2 - Inputs other than quoted prices included in Level 1 available, where (unadjusted) quoted prices are for similar assets and liabilities in non-active markets, or other data that is available or may be corroborated by market data for substantially the full term of the asset or liability.

Level 3 - Inputs for the asset or liability that are not based on observable market data, because market activity is insignificant or does not exist.

As of December 31, 2022, the Company had some assets which the fair value measurement is required on a recurring basis. These assets include investments in private securities and derivative instruments.

Financial assets and liabilities of the Company, measured at fair value on a recurring basis and subject to disclosure requirements of IFRS 7 as of December 31, 2022 and December 31, 2021, are as follows:

Quoted Prices in Non-Active

Markets for Similar Assets

Balance per financial statements

(Level 2)

    

2022

    

2021

    

2022

2021

Current assets

 

Short-term investments

 

2,959,135

2,626,212

2,959,135

2,626,212

Fair value of derivatives

 

3,272

3,246

3,272

3,246

Other current assets

 

789,901

679,193

789,901

679,193

Non-current assets

 

Related parties

 

2,678

2,678

Other non-current assets

 

700,377

571,637

700,377

571,637

 

4,452,685

3,882,966

4,452,685

3,882,966

Current liabilities

 

Short-term debt

 

2,492,262

234,537

2,492,262

234,537

Debentures

628,886

1,531,956

628,886

1,531,956

Fair value of derivatives

 

19,056

19,056

Obligations with FIDC

45,497

45,497

Other current liabilities

 

1,216,206

1,090,396

1,216,206

1,090,396

Non-current liabilities

 

Long-term debt

 

8,687,355

10,875,249

8,687,355

10,875,249

Debentures

 

798,887

1,397,951

798,887

1,397,951

Related parties

24,890

24,648

24,890

24,648

Other non-current liabilities

 

533,681

421,873

533,681

421,873

 

14,401,223

15,622,107

14,401,223

15,622,107

h) Changes in liabilities from Cash flow from financing activities:

The Company has summarized below the changes in the liabilities of cash flow from financing activities, from its Statement of Cash Flows:

Cash transactions

Non cash transactions

Interest expense on

loans and Interest on

Balances as of

Proceeds/(Repayment)

Interest paid on

loans with related

Exchange variation

Balances as of

    

January 1, 2020

    

from financing activities

    

loans and financing

    

parties

    

and others

    

December 31, 2020

Related parties, net

(95,445)

(7,777)

(8,277)

(111,499)

Leasing payable

804,269

(247,914)

(61,727)

61,727

300,119

856,474

Debt, Debentures and Losses/Gains on financial instruments, net - Derivative instruments

16,047,021

(1,963,283)

(1,079,981)

1,022,460

3,490,105

17,516,322

Cash transactions

Non cash transactions

Interest expense on

loans and Interest on

Balances as of

Proceeds/(Repayment)

Interest paid on

loans with related

Exchange variation

Balances as of

December 31, 2020

from financing activities

loans and financing

parties

and others

December 31, 2021

Related parties, net

(111,499)

139,556

(6,089)

2

21,970

Leasing payable

856,474

(275,944)

(68,699)

68,699

337,835

918,365

Debt, Debentures and Losses/Gains on financial instruments, net - Derivative instruments

17,516,322

(4,506,918)

(1,100,826)

1,059,841

1,068,028

14,036,447

Cash transactions

Non cash transactions

Interest expense on

loans and Interest on

Balances as of

Proceeds/(Repayment)

Interest paid on

loans with related

Exchange variation

Balances as of

December 31, 2021

from financing activities

loans and financing

parties

and others

December 31, 2022

Related parties, net

21,970

2,721

199

24,890

Leasing payable

918,365

(310,226)

(88,370)

88,370

422,504

1,030,643

Debt, Debentures and Losses/Gains on financial instruments, net - Derivative instruments

14,036,447

(937,815)

(968,851)

964,607

(471,214)

12,623,174